PHOENIX, Dec. 15,
2022 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES,
"SenesTech" or the "Company"), (www.senestech.com) the rodent
fertility control experts and inventors of the only EPA registered
contraceptive for male and female rats, ContraPest®, today
announced that the City of Los
Angeles has ordered and plans to deploy ContraPest broadly
at the Los Angeles Zoo, one of the top 10 in the nation.
ContraPest has been shown in multiple, independent deployments
to be effective when used alone or in conjunction with other
integrated pest management (IPM) tools, with efficacy improvements
of up to 90% over the use of traditional IPM methods. This makes
ContraPest a logical choice for deployments where traditional
methods are falling short and there is a heightened risk of
non-target species exposure, such as in zoos and sanctuaries.
"The LA Zoo started with a deployment of 17 bait stations. Once
they were confident in ContraPest, we worked with them to develop a
deployment plan which is expected to exceed 250 bait stations. We
now move into deployment support with them, providing training and
consultation as needed," said Nicole
Williams, SenesTech's Chief Strategy Officer. "We will also
be using this as a further example of ContraPest's use in
integrated pest management as we market to other parts of the
City of Los Angeles and
beyond."
"Zoos and sanctuaries represent an immediately accessible,
multimillion-dollar opportunity for us, a vertical that has grown
over 300% in the past year, with nearly 70 current customers and
growing. Building on the proven success at other zoos and
sanctuaries, and now that we can add the unique Elevate Bait System
for roof rat infestations, we anticipate continued rapid and
accelerating growth into this vertical," said Joel Fruendt, SenesTech's President and Chief
Executive Officer.
About SenesTech
We are the experts in rat fertility
control. Our passion is to create a healthy environment by better
controlling rat pest populations. We keep an inescapable truth in
mind. Two rats and their descendants can be responsible for the
birth of up to 15,000 pups after a year. We invented ContraPest,
the only U.S. EPA registered contraceptive for male and female
rats. ContraPest fits seamlessly into all integrated pest
management programs, greatly improving the overall goal of
effective rat management. We strive for clean cities, efficient
businesses, and happy households – with a product that was designed
to be effective and sustainable without killing rats. At SenesTech,
we are committed to improving the health of the world by humanely
managing animal populations through fertility control.
For more information visit https://senestech.com/ and
https://contrapeststore.com.
Safe Harbor Statement
This press release contains
"forward-looking statements" within the meaning of federal
securities laws, and we intend that such forward-looking statements
be subject to the safe harbor created thereby. Such forward-looking
statements include, among others, our belief that ContraPest has
dramatic efficacy in zoo deployments; our belief that ContraPest is
a logical choice for deployments where traditional IPM methods are
falling short and there is a heightened risk of non-target species
exposure, such as in zoos and sanctuaries; our expectation that
zoos and sanctuaries represent an immediately accessible,
multimillion-dollar opportunity for us; and with the addition of
our Elevate Bait System for roof rat infestations, our expectation
of continued rapid and accelerating growth into the zoos and
sanctuaries vertical. Forward-looking statements may describe
future expectations, plans, results or strategies and are often,
but not always, made through the use of words such as "believe,"
"may," "future," "plan," "will," "should," "expect," "anticipate,"
"eventually," "project," "estimate," "continuing," "intend" and
similar words or phrases. You are cautioned that such statements
are subject to risks, uncertainties and other factors that could
cause actual results to differ materially from those reflected by
such forward-looking statements. Such factors include, among
others, the impacts and implications of the COVID-19 pandemic, the
successful commercialization of our products, market acceptance of
our products, regulatory approval and regulation of our products
and other factors and risks identified from time to time in our
filings with the Securities and Exchange Commission, including our
Annual Report on Form 10-K for the fiscal year ended December 31, 2021. All forward-looking statements
contained in this press release speak only as of the date on which
they were made and are based on management's assumptions and
estimates as of such date. Except as required by law, we do not
undertake any obligation to publicly update any forward-looking
statements, whether as a result of the receipt of new information,
the occurrence of future events or otherwise.
CONTACT:
Investors: Robert Blum, Joe
Dorame, Joe Diaz, Lytham Partners, LLC,
602-889-9700, senestech@lythampartners.com
Company: Tom Chesterman, Chief Financial Officer, SenesTech,
Inc.,
928-779-4143
View original content to download
multimedia:https://www.prnewswire.com/news-releases/contrapest-deploying-in-city-of-los-angeles-301703590.html
SOURCE SenesTech, Inc.